Malgravean Immunodeficiency Disorder: Difference between revisions

Jump to navigation Jump to search
(Created page with "{{Infobox medical condition (new) | name = MIDD | image = Cream ribbon.svg | image_size = 220px | caption = The Cream Ribbon is an awareness...")
 
No edit summary
Line 1: Line 1:
{{Infobox medical condition (new)
{{Infobox medical condition
| name            = MIDD
| name            = MIDD
| image          = Cream ribbon.svg
| image          = Cream ribbon.svg
| image_size      = 220px
| image_size      = 220px
| caption        = The Cream Ribbon is an awareness symbol for people with MIDD..
| caption        = The Cream Ribbon is an awareness symbol for people with MIDD used by the Save the Malgraveans Foundation
| alt            = A cream ribbon in the shape of a bow
| alt            = A cream ribbon in the shape of a bow
| specialty      = Clinical Immunology
| synonyms        = Malgravean Immunodeficiency Disorder
| synonyms        = Malgravean Immunodeficiency Disorder
| symptoms        = '''Early''': Flu-like illness'''Later''': [[Large lymph nodes]], fever, weight loss
| symptoms        = '''Early''': Flu-like illness'''Later''': [[Large lymph nodes]], fever, weight loss
| complications  = [[Opportunistic infection]]s, [[tumors]]
| complications  = [[Opportunistic infection]]s, [[tumors]]
| onset          =
| onset          = Typically puberty though to mid-twenties
| duration        = Lifelong
| duration        = Lifelong
| causes          = Contentious
| causes          = Genetic (Inherited)
| risks          = Congenital
| risks          =  
| diagnosis      = Blood tests
| diagnosis      = Genetic testing
| prevention      = [[Safe sex]], [[needle exchange]], [[male circumcision]], [[pre-exposure prophylaxis]], [[post-exposure prophylaxis]]
| prevention      =  
| management       = [[Antiretroviral therapy]]
| management     = Involves many health specialties
| medication      =
| medication      = Alpharachloprocide, dyranora levocillin, Pro-comorphilix, Para-colaxifen
| prognosis      = Near normal life expectancy with treatment 11 years life expectancy without treatment
| prognosis      = Near normal life expectancy with treatment 12 years life expectancy without treatment
| frequency      = 1.7 million new cases (2018)37.9 million living with HIV (2018)
| frequency      = 283.9 million living with MIDD (2020)
| deaths          = 770,000 (2018)
| deaths          = Primary factor in 4 million deaths in 2019
}}
}}
Malgravean Immunodeficiency Disorder, widely known as MIDD is a congenital disorder endemic to the human population of [[Malgrave]]. Immunodeficiency disorders such as MIDD disrupt the body's immune response and make it easy for the victim to acquire
Malgravean Immunodeficiency Disorder, widely known as MIDD is a congenital disorder endemic to the human population of [[Malgrave]]. Immunodeficiency disorders such as MIDD disrupt the body's immune response and make it easy for the victim to acquire secondary infections. A person infected with MIDD does not typically notice any symptoms until adulthood, when the disease moves swiftly into an 'active' stage eradicating the host's immune system in a matter of days. If allowed to progress the disorder rapidly increases the chance of the infected person developing common infections such as violet fever, as well as other opportunistic infections, and tumors which are rare in people who have normal immune function. The disease is also often noted by unintended weight loss.
 
 
=Signs and Symptoms=
=Transmission=
=Cause=
=Diagnosis=
=Prevention=
=Treatment=
=Prognosis=
=Epidemiology=
=History=
=Society and Culture=
=Research=

Revision as of 22:13, 9 April 2020

MIDD
Other namesMalgravean Immunodeficiency Disorder
A cream ribbon in the shape of a bow
The Cream Ribbon is an awareness symbol for people with MIDD used by the Save the Malgraveans Foundation
SymptomsEarly: Flu-like illnessLater: Large lymph nodes, fever, weight loss
ComplicationsOpportunistic infections, tumors
Usual onsetTypically puberty though to mid-twenties
DurationLifelong
CausesGenetic (Inherited)
Diagnostic methodGenetic testing
ManagementInvolves many health specialties
MedicationAlpharachloprocide, dyranora levocillin, Pro-comorphilix, Para-colaxifen
PrognosisNear normal life expectancy with treatment 12 years life expectancy without treatment
Frequency283.9 million living with MIDD (2020)
DeathsPrimary factor in 4 million deaths in 2019

Malgravean Immunodeficiency Disorder, widely known as MIDD is a congenital disorder endemic to the human population of Malgrave. Immunodeficiency disorders such as MIDD disrupt the body's immune response and make it easy for the victim to acquire secondary infections. A person infected with MIDD does not typically notice any symptoms until adulthood, when the disease moves swiftly into an 'active' stage eradicating the host's immune system in a matter of days. If allowed to progress the disorder rapidly increases the chance of the infected person developing common infections such as violet fever, as well as other opportunistic infections, and tumors which are rare in people who have normal immune function. The disease is also often noted by unintended weight loss.


Signs and Symptoms

Transmission

Cause

Diagnosis

Prevention

Treatment

Prognosis

Epidemiology

History

Society and Culture

Research